Latest / Pharmacy Podcast Network / Advantages of Levothyroxine Capsule Over Tablet | YARAL Pharma
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:30Speaker 2: Each year, millions of patients are treated with levothyroxine to
- 0:34Speaker 2: manage hyperthyroidism, but not alllevothyroxine medications are created equal. On
- 0:39Speaker 2: today's Pharmacy Podcast Network episode, we're discussing the management of
- 0:43Speaker 2: hypothyroidism and why the answer for some patients who may
- 0:46Speaker 2: have trouble tolerating traditional tablets could lie in the dosage form.
- 0:50Speaker 2: Sonya O'Brien is not affiliated with Your All Pharma. All
- 0:54Speaker 2: of the views and opinions stated are hers solely and
- 0:56Speaker 2: are not attributed to Your All Pharma.
- 0:58Speaker 3: Hey, welcome to the Pharma see podcast networks You're All
- 1:02Speaker 3: Pharma podcast series. This is our second series together and
- 1:08Speaker 3: I have back in the studio with me the CEO
- 1:11Speaker 3: of you'rre Al Pharma, Steve Beckman. Welcome to the show again, Steve,
- 1:15Speaker 3: and it's so good to see.
- 1:17Speaker 4: It's a pleasure to be here. I liking this so much.
- 1:19Speaker 4: I'm going to have to change careers and maybe become
- 1:21Speaker 4: a podcaster, so it's a pleasure to.
- 1:24Speaker 3: Don't do it, don't do it. We have a special
- 1:27Speaker 3: guest with us, doctor Sonya O'Brien, who I met through
- 1:31Speaker 3: a special friend from Alps Pharmacy and the consultancy that
- 1:35Speaker 3: you do your world of holistic medicine as well as
- 1:39Speaker 3: understanding nutraceuticals in the world of our of our hormones. Sonya,
- 1:44Speaker 3: We're so excited to have you here today.
- 1:47Speaker 5: Thank you so much. Happy to be here.
- 1:50Speaker 3: All right. So we're going to be touching on some
- 1:53Speaker 3: of the innovative technologies that you'rale has. The Pharmacy Podcast
- 1:57Speaker 3: Network has been talking about for quite some time now,
- 2:00Speaker 3: about six to nine months of content that we've been
- 2:03Speaker 3: really focusing on and giving an opportunity for our pharmacists
- 2:08Speaker 3: to learn more about some of the options around thyroid treatment,
- 2:13Speaker 3: around many of the aspects that are impacting I'm thinking
- 2:17Speaker 3: of seniors, Steven, because our senior population, we haven't even
- 2:21Speaker 3: gotten to the top of the hill yet about what's
- 2:24Speaker 3: happening to our population three hundred and thirty million Americans
- 2:28Speaker 3: right now and my parents, for example, in their mid
- 2:32Speaker 3: to late seventies. I'm going to be part of that.
- 2:35Speaker 3: I'm fifty two, so in twenty years i'll be where
- 2:38Speaker 3: they're at and we're going to need a lot more
- 2:41Speaker 3: pharmacists really digging down into pain management and hypertension and
- 2:46Speaker 3: diabetes and weight management, and a lot of that plot
- 2:51Speaker 3: plugs into some of what we're talking about today, So
- 2:53Speaker 3: kind of give our listeners a summary of what we're
- 2:57Speaker 3: going to be getting into.
- 2:58Speaker 4: Well, you know, I think you're right. I think see
- 3:00Speaker 4: we all know that the population is aging, uh, and
- 3:03Speaker 4: those numbers are going to go up, so you know,
- 3:05Speaker 4: issues around hyperthyroism and other things are are going to
- 3:10Speaker 4: grow and they're going to be more challenging. So having
- 3:15Speaker 4: solutions and you know, it's interesting if we go back
- 3:17Speaker 4: to the podcast that we've had in the past, UH
- 3:19Speaker 4: taught about pain management. One of the things with the
- 3:22Speaker 4: experts we had with the pain Guy was you talked
- 3:26Speaker 4: that one of the most important things about pain and
- 3:28Speaker 4: managing pain is having options. So you know, when we
- 3:32Speaker 4: think of something like a product for hyperthyroism, I think
- 3:36Speaker 4: that's kind of the same parallel path. You know, we've
- 3:39Speaker 4: been traditionally using the same things for a long period
- 3:41Speaker 4: of time. And for those that works really well, that's great,
- 3:44Speaker 4: and for the for those that it doesn't work as well,
- 3:47Speaker 4: that's not so great, right, especially when you're talking about
- 3:49Speaker 4: a chronic condition and things like that. So I think
- 3:51Speaker 4: what we're we're always doing, what's really the basis of
- 3:55Speaker 4: c HR parent company and our sister company USA and
- 3:59Speaker 4: you're out, is we're really focused on trying to take
- 4:02Speaker 4: products and making them better. And what that really means
- 4:04Speaker 4: is is that we're making tweaks to the things to
- 4:07Speaker 4: some of these products that might not traditionally fit everybody
- 4:11Speaker 4: that's in that patient population because there are subpopulations. And
- 4:15Speaker 4: I think what's critical in the case of hyperthighroism is
- 4:18Speaker 4: that lebothoroxin is the main stay and then the different
- 4:21Speaker 4: products that are available for that to treat it. But
- 4:24Speaker 4: there have been a history of tolerability and we have
- 4:27Speaker 4: a product that addresses that. So in that case, there's
- 4:30Speaker 4: a patient patient population that might have a better out
- 4:35Speaker 4: potentially better outcome, or at least an option to consider
- 4:38Speaker 4: other things to use that might be better for their
- 4:41Speaker 4: perturcular circumstances. And back to your original question, if that
- 4:44Speaker 4: population is growing, then there's going to be more people
- 4:47Speaker 4: that are going to be required or demanding something that's
- 4:50Speaker 4: going to work better for them. And at the bottom line,
- 4:52Speaker 4: if you have a chronic product or a chronic disease,
- 4:55Speaker 4: if you don't take it, you're not going to get
- 4:57Speaker 4: the outcome. And then the spill over effect is obviously
- 4:59Speaker 4: those patients don't do as well, and there's other things
- 5:02Speaker 4: that can happen with those in the cross coome abilities
- 5:04Speaker 4: and other things like that. So the point is, you know,
- 5:08Speaker 4: we were trying to create products and understand that all
- 5:11Speaker 4: these populations all have subpopulations within it, and if we
- 5:15Speaker 4: can create solutions and opportunities that will fit them, then
- 5:19Speaker 4: we're going to have better outcome.
- 5:21Speaker 3: And Sonya, these solutions are being created for the quarterback
- 5:26Speaker 3: our physicians and then passing that treatment ball. It's football season,
- 5:30Speaker 3: so I can't help it passing it to you the
- 5:33Speaker 3: pharmacists to drive that treatment. Talk to our listeners, open
- 5:38Speaker 3: up and tell us a little bit about your background, Sonya,
- 5:41Speaker 3: and how you've helped people with hormones as well as
- 5:45Speaker 3: the natural side, the blend between pharmacology and the natural
- 5:49Speaker 3: side of health.
- 5:52Speaker 5: Sure, I'm privileged to work in the area of both,
- 5:57Speaker 5: you know, pharmaceuticals but also the natural side, and so
- 6:01Speaker 5: on any given day, I have patients coming my way
- 6:05Speaker 5: wanting to know more about their hormones, how those hormones
- 6:08Speaker 5: are processing in their bodies, the things that are involved
- 6:12Speaker 5: in how hormones work. And when we talk about hormones,
- 6:16Speaker 5: that's a pretty broad word, you know, in that you're
- 6:18Speaker 5: going to find your estrogens, your progesterone, your testosterone, but
- 6:22Speaker 5: also you know, thyroid is really a hormone too, and
- 6:27Speaker 5: so you know, making that system work well for patients,
- 6:31Speaker 5: they'll say, sometimes I just don't feel quite right and
- 6:36Speaker 5: what can I do to sort of get to the
- 6:38Speaker 5: bottom of this. Totally respect physicians where they're at. I
- 6:42Speaker 5: have physicians that actually refer patients over for this niche
- 6:47Speaker 5: of care that I provide, but I customize therapies for
- 6:50Speaker 5: patients on the day to day, literally putting you know,
- 6:55Speaker 5: compounded medications together for them. I often will will go
- 7:00Speaker 5: the route of integrative supplements to help them. We're there,
- 7:05Speaker 5: I mean, this younger generation, they like that especially I
- 7:10Speaker 5: do too, though, you know, I love taking certain things
- 7:14Speaker 5: to help my body be optimized. So that's the day
- 7:18Speaker 5: to day for me, you know. And I'm a front
- 7:20Speaker 5: facing pharmacist in the midst of all of that. Just
- 7:24Speaker 5: knowing medications, knowing how certain things interact the challenges for
- 7:30Speaker 5: patients and working both sides of all of that to
- 7:35Speaker 5: help them.
- 7:37Speaker 3: I like how you gave us a lead into really
- 7:41Speaker 3: the effective management of hypothyroidism and why that's so important.
- 7:46Speaker 3: So that's kind of what I'm going to kick off
- 7:47Speaker 3: to you right out of the gates on you. Why
- 7:50Speaker 3: is it important to really understand the management of hyperthyroidism?
- 7:56Speaker 5: Right? So you know patients, I say that patients symptoms
- 7:59Speaker 5: can be deceiving sometimes and you know, working with their
- 8:03Speaker 5: physician to know is is it a hormone issue, is
- 8:07Speaker 5: it stress and adrenals? Is it the thyroid? Symptoms can
- 8:12Speaker 5: mimic when we talk about these things, and so you know,
- 8:18Speaker 5: I often will get lab work on patients and working
- 8:21Speaker 5: with that physician for that patient and and just working
- 8:25Speaker 5: to optimize the thyroid in addition to the hormone levels
- 8:30Speaker 5: and everything else. So you know, the fatigue, the weight gain,
- 8:34Speaker 5: the hair loss, some of these things that patients are
- 8:36Speaker 5: struggling with can look very much like just you know,
- 8:39Speaker 5: hormones too. So getting to the root cause, I think
- 8:43Speaker 5: is where I serve in my role, you.
- 8:47Speaker 4: Know, Tuck, Can I say something that I think what's
- 8:49Speaker 4: interesting about what Susanias saying is is that you know,
- 8:52Speaker 4: you know, simplicity. I when I was in business school,
- 8:55Speaker 4: one of my my teachers always said to me is
- 8:57Speaker 4: that sometimes less is more, and you know, sometimes we
- 9:01Speaker 4: don't always follow that, but I think that can be
- 9:03Speaker 4: applied to anything in life or business or you know,
- 9:06Speaker 4: treating patients. And I guess what I was hearing, and
- 9:09Speaker 4: Sonny can correct me if I've heard it differently but
- 9:12Speaker 4: are wrong. But the point is is that I think
- 9:14Speaker 4: that's one of the benefits of like the product that
- 9:16Speaker 4: we have in terms of legothrox and capsules, because we
- 9:20Speaker 4: only have four ingredients. You know, it's simple, clean, and
- 9:25Speaker 4: you know when you're talking that we only have lego throxin,
- 9:27Speaker 4: we have sodium excuse me, of lebotherroxin, gelatin, glacerin water.
- 9:34Speaker 4: We're making it simple. And when you're working with a
- 9:36Speaker 4: body and all the dynamics of the body, you probably
- 9:39Speaker 4: don't want anything else that you need to That's always
- 9:41Speaker 4: a rule thumb. So I think that's one of the
- 9:43Speaker 4: things that makes it simple for us, is that that's
- 9:46Speaker 4: what we want to do. And then from a tolerability standpoint,
- 9:51Speaker 4: tolerability is usually because there's multiple factors and things, and
- 9:54Speaker 4: you're working with multiple medications and things like that. So again,
- 9:57Speaker 4: something that has a very clean profile on the drug
- 10:00Speaker 4: profile should make it a be a good opportunity for
- 10:04Speaker 4: those patients that have tolerability. Simple as good I think,
- 10:07Speaker 4: I guess is what I'm hearing, Well.
- 10:09Speaker 5: It is good.
- 10:10Speaker 3: And then the combination of the natural side of things
- 10:14Speaker 3: that you're discovering Sonya, really is a huge interest. Matter
- 10:18Speaker 3: of fact, before we started recording, Steph and I were
- 10:21Speaker 3: both saying, hey, we're at a different age than It's
- 10:24Speaker 3: strange to say it, but we're were the age that
- 10:28Speaker 3: I remember my dad being. You know what I mean.
- 10:30Speaker 3: It's just like it's weird to finally wake up one
- 10:32Speaker 3: day and I'm fifty and we have to make some
- 10:35Speaker 3: decisions about our own life. I'm starting weight training again.
- 10:39Speaker 3: I'm starting to pay attention to what I'm eating. And
- 10:42Speaker 3: when I think of people that are suffering with specific
- 10:45Speaker 3: conditions that their pharmacists could dial in, and that's exactly
- 10:49Speaker 3: what you said, Sonya was dialing in. It makes me
- 10:52Speaker 3: maintaining a component of this whole thing is maintaining consistent
- 10:56Speaker 3: T four levels that are important for patients with hypu ybroidism,
- 11:00Speaker 3: And I kind of wanted to kick that to use
- 11:02Speaker 3: on you and get kind of your feedback with that.
- 11:06Speaker 5: Yeah, so you know that steady state level of medications
- 11:10Speaker 5: is where the magic is. It's the same with hormones
- 11:15Speaker 5: and patients having fluctuations up and down, and you know,
- 11:20Speaker 5: not getting that right can have an impact on them
- 11:24Speaker 5: with fatigue, with with sweats, with you know, heart rate
- 11:29Speaker 5: or whatever the case may be. And so multiple medications.
- 11:35Speaker 5: You know, looking at that, what are they on? Are
- 11:37Speaker 5: there things in these products that we need to drill
- 11:43Speaker 5: down on. I mean we're seeing an uptick even in
- 11:45Speaker 5: alpha gal right now, and we have to consider things
- 11:50Speaker 5: like that with the di I tolerability and things like that.
- 11:53Speaker 5: So yeah, we have to look at steady state, how
- 11:57Speaker 5: they're taking it, when they're taking it, when to a
- 12:00Speaker 5: void food, how long to avoid food before taking it.
- 12:03Speaker 5: These are all important for the patient to know. And
- 12:06Speaker 5: I think pharmacist are very critical because we're they're counseling
- 12:10Speaker 5: that patient, as I said, front facing, getting that information
- 12:15Speaker 5: across that counter to them.
- 12:18Speaker 4: You know, Todd, you know what's great to hear is
- 12:20Speaker 4: the word UH is essential to maintain levels. Because one
- 12:25Speaker 4: of the things when we look at this product in
- 12:27Speaker 4: particular is UH is how important it is to maintain
- 12:31Speaker 4: the steady TEA level is essential to theroid management. And
- 12:35Speaker 4: you know, that's one of the things in our peer
- 12:37Speaker 4: technology that we use for our CAPS development our products
- 12:43Speaker 4: is it allows us to ensure reliable bioavailability and that
- 12:46Speaker 4: really supports that consistent therapeutic effect. And so for us
- 12:53Speaker 4: in this hormones and thyroid everything, steady state is really
- 12:58Speaker 4: what you're must maintain. If you're not stay state, that's
- 13:01Speaker 4: when you get off balance obviously. So I think that's
- 13:04Speaker 4: one of the things that when you look behind the
- 13:06Speaker 4: product outside the fact that it's form factor is just
- 13:09Speaker 4: different than tablets and we can really address the potential
- 13:14Speaker 4: of tolerability for patients that struggle with that, is that
- 13:16Speaker 4: we have a product that we also know will help
- 13:19Speaker 4: ensure through it's a consistent bioavailability, a steady state. And
- 13:23Speaker 4: so hopefully that's another that's another benefit ultimately in terms
- 13:27Speaker 4: of the patient getting the right outcome.
- 13:30Speaker 3: I think that that relationship, going back to what we
- 13:32Speaker 3: were saying Sonya about that you get this initial prescription,
- 13:38Speaker 3: you get kind of like the treatment plan. You're going
- 13:40Speaker 3: down the road as a patient, something happens where it's
- 13:44Speaker 3: just not working. I reach out to a specialist that
- 13:47Speaker 3: understand it. I reach out to you, Sonya to start
- 13:49Speaker 3: asking my questions. So explain to us some of the
- 13:53Speaker 3: common challenges that are faced by patients taking a lebothiroxine
- 13:57Speaker 3: tablet to treat a hype thy really isn't.
- 14:02Speaker 5: Yeah, So the time of day to take it, you know,
- 14:04Speaker 5: it's best taken on an empty stomach. You have to
- 14:08Speaker 5: wait for a certain amount of time before you eat.
- 14:11Speaker 5: What if there's a challenge with that. A person that
- 14:14Speaker 5: you know wakes up and you know, it could be
- 14:17Speaker 5: blood sugar management. They've got things going on there with
- 14:20Speaker 5: blood sugar, and so that can be a factor. Availability
- 14:27Speaker 5: of the prescription, you know, this is covered. This is
- 14:31Speaker 5: not covered. This just access to certain medications. Osteoporosis. You know,
- 14:39Speaker 5: I'm on calcium for my osteoporosis. Well, that's a medication
- 14:43Speaker 5: that we want to separate from from thyroid medications. So
- 14:47Speaker 5: just you know, good counseling look in each and every person.
- 14:50Speaker 3: What are their.
- 14:51Speaker 5: Conditions, what are their medications, what are their lifestyle needs?
- 14:57Speaker 5: To help manage this and then you know, follow up
- 15:01Speaker 5: with their doctor to get those lab levels to see
- 15:05Speaker 5: if they're having you know, good success with steady state.
- 15:11Speaker 3: So I think of follow up in how many people
- 15:17Speaker 3: you've gotten contact with Steven who you might have been
- 15:21Speaker 3: at a conference, or you might have talked to somebody,
- 15:22Speaker 3: you might have heard somebody do a panel discussion. Are
- 15:26Speaker 3: there other things that you've heard come up in the
- 15:28Speaker 3: treatment that has been injected to the ideas to really
- 15:33Speaker 3: help hone in on treatment for a specific patient.
- 15:38Speaker 4: Nothing probably per se specifically, But I think the most
- 15:41Speaker 4: important thing at what Sonia said is that you know,
- 15:44Speaker 4: at the pharmacist level or a physician level, it's really
- 15:47Speaker 4: managing the patient individually. And you know, sometimes we get
- 15:53Speaker 4: in the position where we kind of do suad bross
- 15:55Speaker 4: of this is how we should treat a asthma patient,
- 15:58Speaker 4: or this is how we should treat this patient. But
- 16:00Speaker 4: I think to your point about us getting old and
- 16:02Speaker 4: it's just a minute, it's it's we're old then or older,
- 16:07Speaker 4: is that we do have comobidities, We have different dynamics
- 16:13Speaker 4: in terms of it. I might have a high sugar level,
- 16:16Speaker 4: maybe somebody's free diabetic versus diabetic versus not And I
- 16:20Speaker 4: think ultimately what we have to do is we have
- 16:23Speaker 4: to give the pharmacy, the pharmacists, and the physicians the
- 16:26Speaker 4: ability to really do what Sonia said, which is to
- 16:30Speaker 4: treat people on an individual basis. And I think that
- 16:32Speaker 4: we're all trying to ensure that we get the best
- 16:35Speaker 4: outcome for the patient and we have to deal with
- 16:37Speaker 4: compliance challenges and coor mobility as I said, and other things.
- 16:42Speaker 4: So the messages is that you also have to give
- 16:45Speaker 4: them the tools, right and those tools come in the
- 16:49Speaker 4: form of many different ways, and I think that's what
- 16:52Speaker 4: you know, the simple premise of something like tears and
- 16:55Speaker 4: caps provides is that it's a tool, it's an option.
- 16:59Speaker 4: It's some that can be considered appropriate by the appropriate people.
- 17:03Speaker 4: I would never suggest myself to making a suggest the
- 17:05Speaker 4: patient because I am not a pharmacist, I am not
- 17:08Speaker 4: a doctor. But our goal is to give the information
- 17:11Speaker 4: order for Sonia and the physicians we work with to say, hey,
- 17:15Speaker 4: we have this patient, this conditionous situation, are there are
- 17:18Speaker 4: there other alternatives we need to look at in its
- 17:21Speaker 4: holistic nature, And you know, ultimately to what Sonia was
- 17:26Speaker 4: saying is that I think the younger generations that are
- 17:28Speaker 4: coming up is that there always has been, but maybe
- 17:32Speaker 4: we're going through a cycle which I think is appropriate
- 17:35Speaker 4: where we're looking at traditional medicine, non traditional medics and
- 17:38Speaker 4: other things that we do both for physical and mental health.
- 17:41Speaker 4: And that's it at the bottom. Idea is the data
- 17:45Speaker 4: supports that this is a good product in levil theraction
- 17:49Speaker 4: as a whole, as a as a treatment category, and
- 17:52Speaker 4: now you have the different the different tools within that
- 17:56Speaker 4: box to say what's best for that patient. So not
- 17:58Speaker 4: to se there's there's something new and novel. I think
- 18:01Speaker 4: it's just a matter of doing it right and getting
- 18:03Speaker 4: back to what we really need to do, and that
- 18:05Speaker 4: is to treat people at an individual level and get
- 18:09Speaker 4: them the right resources ensures a successful outcome. Again, I
- 18:13Speaker 4: love that word outcome, but that's what we do every day,
- 18:16Speaker 4: try to improve the.
- 18:16Speaker 3: Oulcohols, striving for outcomes. I want to shift it back
- 18:20Speaker 3: to you, Sonya and ask about dosage form and how
- 18:24Speaker 3: that could be an important factor to consider when your
- 18:27Speaker 3: physician is prescribing a libothirox in what the patient has
- 18:32Speaker 3: to pay attention to and then the guidance that you
- 18:35Speaker 3: provide as a pharmacist.
- 18:38Speaker 5: So yeah, you know, leave what that roxine comes in
- 18:40Speaker 5: many strengths, and typically you'll see them start low and
- 18:45Speaker 5: work up. They need to be paying attention to that
- 18:48Speaker 5: when they start. You know, if I have a preference
- 18:52Speaker 5: between just taking a capsule or a tablet, I will
- 18:56Speaker 5: pick a capsule every time, just to be able to
- 18:59Speaker 5: swallow it easy. I think some patients just do better
- 19:03Speaker 5: with that alone. These tablets get stuck in my throat
- 19:06Speaker 5: or whatever the case may be. I hear that from
- 19:09Speaker 5: time to time. I love when we can use less
- 19:14Speaker 5: is more, I think is where we were talking when
- 19:17Speaker 5: we first started. But the fewer ingredients for me, the
- 19:21Speaker 5: better give me, give me the thing I need and
- 19:24Speaker 5: just only the essentials that that are needed to make
- 19:28Speaker 5: that work. And I love having fewer ingredients. There can
- 19:32Speaker 5: be some allergies, as I said to you know, all
- 19:35Speaker 5: these things that people add, the dies and the fillers
- 19:39Speaker 5: and and these things that we find sometimes in these tablets.
- 19:43Speaker 5: I've had to pull package inserts many times over the
- 19:46Speaker 5: years and just really look closely at those ingredients.
- 19:50Speaker 4: So well, you know, I actually want to get on
- 19:53Speaker 4: a plane and fly on and shake your hand, because
- 19:58Speaker 4: come on one is just a little bit of history
- 20:02Speaker 4: toat so actually, you know, soft capsules were actually invented
- 20:05Speaker 4: back in the nineteen thirties and basically they were invented
- 20:09Speaker 4: to hide tasting of a smell or taste to the
- 20:15Speaker 4: medicine and so forth. So I mean, there's a good
- 20:17Speaker 4: reason to do that. So I love the fact that
- 20:20Speaker 4: Sony A. Beilieves that that's important tabats or tabits, but
- 20:23Speaker 4: you know, there are some benefits of capsules, and she
- 20:25Speaker 4: highlighted on a key one. So that's really important and
- 20:29Speaker 4: simple as simple, and I think that's another thing we
- 20:32Speaker 4: like to do. So it's like everything I wanted to
- 20:34Speaker 4: share today, she's teed it up correct. Thank you for
- 20:38Speaker 4: that and a little history lesson. But I would have
- 20:40Speaker 4: some of my team that came up with that background
- 20:43Speaker 4: data that I put in my head.
- 20:46Speaker 3: Yeah, I think of the increasing needs of seniors, the
- 20:51Speaker 3: fact that our senior population is living longer because we
- 20:55Speaker 3: have more access to good medications, better therapies. Are pharmacist
- 20:59Speaker 3: and now start to step outside of the of the
- 21:03Speaker 3: bench and they're starting to think how can we help
- 21:05Speaker 3: people live better lives longer and then ling into their
- 21:10Speaker 3: specifics Sonya. There are sports oriented seniors now, there are
- 21:15Speaker 3: competitive seniors now with triathlons, and there's seniors that are
- 21:19Speaker 3: are extending their life twenty thirty forty years because of
- 21:23Speaker 3: the way that they're living. Have you seen an increase
- 21:27Speaker 3: in thyroid issues? Are you seeing any trends at all
- 21:31Speaker 3: in the Midwest? And you know, share with our listeners
- 21:35Speaker 3: a little bit about that as well.
- 21:37Speaker 5: You know, I've been doing this a long time. I've
- 21:39Speaker 5: been doing custom therapies for patients, you know, twenty five
- 21:43Speaker 5: years working I was doing hormones in custom medicine when
- 21:47Speaker 5: people hardly even knew about it. But something I've noticed
- 21:53Speaker 5: over the years is, you know, significant disease, something major
- 21:59Speaker 5: happens to a person, and you know there can be
- 22:00Speaker 5: some thyroid issues that happen with that hysterectomies. It seems
- 22:08Speaker 5: like there can be some connections there, just just in
- 22:10Speaker 5: talking with patients, like just it's not optimized like it
- 22:14Speaker 5: was when those ovaries aren't talking to the thyroid and
- 22:18Speaker 5: so forth. That's That's something else I've seen. And just
- 22:22Speaker 5: I think the high stress that people are living under
- 22:25Speaker 5: these days and the inflammation that we're surrounded by every
- 22:31Speaker 5: second of the day. I think these things are playing
- 22:34Speaker 5: into you know, the disease processes and how we need
- 22:40Speaker 5: to manage people to try to help those things too.
- 22:43Speaker 4: Well, that's a good point. I mean, the fact is
- 22:45Speaker 4: that we live in a very different world, right There
- 22:47Speaker 4: are more stresses in the world and things like that,
- 22:51Speaker 4: and that will play different impact on your body. I
- 22:54Speaker 4: think the other thing that I forgot to mention too
- 22:56Speaker 4: is that you know, we put a tremendous amount of
- 22:59Speaker 4: pressure on our farms and our physicians. You know, our
- 23:02Speaker 4: physicians have staff and they can always have support, but
- 23:05Speaker 4: a lot of times pharmacists are working alone, and especially
- 23:09Speaker 4: if they're not in a big pharmacy and they're they're
- 23:11Speaker 4: they're treating people. And one of the things Sonya said
- 23:14Speaker 4: was is that sometimes I have to go back and
- 23:17Speaker 4: understand the pis associated with drugs, and these drugs can
- 23:20Speaker 4: be very complicated. You know. Part of what we should
- 23:22Speaker 4: be doing is helping out pharmacists not have that heavy lift,
- 23:25Speaker 4: you know, to be able to be able to be
- 23:27Speaker 4: confident they know a product pretty well because it is,
- 23:30Speaker 4: you know, something that is easy to understand from a
- 23:33Speaker 4: standpoint of how dynamic the drug is. So you know,
- 23:36Speaker 4: a simple drug in terms of its makeup, because I
- 23:41Speaker 4: would think some confidence to you as as a pharmacist too.
- 23:44Speaker 4: So okay, we all have big burdens, and it's not
- 23:47Speaker 4: just the patience and what they're changing, but it's how
- 23:50Speaker 4: you know, the pharmacists and physicians and all healthcare providers
- 23:53Speaker 4: have to deal with. So it's our job to try
- 23:56Speaker 4: to make it simple is better so that we can
- 23:59Speaker 4: actually be more orf faective. So maybe that's our new
- 24:01Speaker 4: model as simple as better for how we interact between
- 24:05Speaker 4: our providers, our patients, and the suppliers of medicines and
- 24:08Speaker 4: others to make it easier for patients ultimately comprehend and
- 24:15Speaker 4: be compliant to what they're doing in order to see
- 24:20Speaker 4: those thirty forty years. And that's why Todd Nyer after
- 24:23Speaker 4: the show today, we'll talk more about in our advanced
- 24:26Speaker 4: age what we're going to do to see those thirty
- 24:28Speaker 4: or forty years.
- 24:29Speaker 3: But that's right, that's right. Patients that you're helping with
- 24:35Speaker 3: maybe thyroid issues or hormone issues, Sonya, talk to us
- 24:39Speaker 3: about other things that could come into play. We're talking
- 24:42Speaker 3: about their diets, we're talking about some of their exercise
- 24:45Speaker 3: pharmacists are becoming an extension of just a not just
- 24:49Speaker 3: a pharmacist medication management, because that in itself is enough,
- 24:53Speaker 3: but you're also becoming health coaches. You're also giving kind
- 24:56Speaker 3: of advice to their sense ativities around sugars or dyes
- 25:02Speaker 3: or alcohol or something that might be an extra thing
- 25:07Speaker 3: that's impacting someone else versus me or Steven or yourself.
- 25:12Speaker 3: So talk to us about that facet of patient management
- 25:16Speaker 3: and treatment management.
- 25:18Speaker 5: I think, you know, going back to you talking about
- 25:21Speaker 5: your parents, I think my parents had just a slower
- 25:25Speaker 5: pace to life. I think our schedules are very busy.
- 25:29Speaker 5: It's the lights, the action, the drive throughs, all you know,
- 25:34Speaker 5: schedules and all of the things that we're trying to
- 25:38Speaker 5: manage in addition to our jobs and our home life
- 25:43Speaker 5: and this sort of thing more anxiety, more depression. People
- 25:49Speaker 5: are not sleeping very well. When I work with the patient,
- 25:52Speaker 5: if there's one thing on the list that they're sharing
- 25:54Speaker 5: to me, and it's sleep, that's going to be my
- 25:57Speaker 5: primary target is to try to help them get more
- 26:00Speaker 5: RESTful sleep, because that is the reset to our to
- 26:04Speaker 5: our body, and so those things, you know, we can
- 26:08Speaker 5: see it in prescriptions, pain management and anxiety and depression.
- 26:13Speaker 5: They're they're just on the rise as people try to to,
- 26:17Speaker 5: you know, cope with life and the demands of life.
- 26:20Speaker 5: So that's important. Lifestyle medicine. You know, are you exercising?
- 26:25Speaker 5: And I tell patients, okay, let's keep it simple, you know,
- 26:28Speaker 5: can you give me a plan exactly? And I'm like,
- 26:30Speaker 5: just keep it simple. I just want you to walk
- 26:32Speaker 5: thirty minutes a day, five to six days a week.
- 26:36Speaker 5: You don't need to be training for a marathon, but
- 26:39Speaker 5: get out. I like you to touch the ground, take
- 26:42Speaker 5: your shoes off, touch touch the ground, and just enjoy
- 26:45Speaker 5: it like you did when you were a kid. Walk
- 26:47Speaker 5: on the beach. These sorts of things are important. Eating well,
- 26:53Speaker 5: you know, we have access. I could be at a
- 26:56Speaker 5: drive through in two minutes from my office here, and
- 27:00Speaker 5: that's that's not great, you know if that's the only
- 27:03Speaker 5: place that you're visiting every day. So good food is
- 27:08Speaker 5: important to our bodies. Good food actually helps how hormones
- 27:12Speaker 5: metabolize in our bodies. Food is medicine, just like a
- 27:16Speaker 5: Pocrates said about it. So those would be things that
- 27:19Speaker 5: I would I would mention.
- 27:22Speaker 3: You see that tying into any gastro intestinal issues or
- 27:28Speaker 3: anything where absorption becomes an issue.
- 27:30Speaker 5: Sonya, oh, absolutely, yeah. In one of the tests I provide,
- 27:35Speaker 5: we can actually look at a gut marker. It's important
- 27:39Speaker 5: for the gut to be healthy so that we can
- 27:42Speaker 5: absorb things appropriately. And I think our foods, you know,
- 27:50Speaker 5: are not the same as they used to be with
- 27:53Speaker 5: some of the things that are being used in our foods.
- 27:56Speaker 4: And that's good to hear because obviously with those the caps,
- 28:00Speaker 4: we maintain a consistent absorption even in altered states within
- 28:03Speaker 4: the gut. So again you have to look at it holistically.
- 28:07Speaker 4: So if you're if you're trying to get an outcome
- 28:09Speaker 4: and a certain things, and we all know that medicine
- 28:12Speaker 4: is going to have That's why we have side effects
- 28:14Speaker 4: and aes and we have to maintain and with the
- 28:18Speaker 4: government and the regulatory authority is always about the quality
- 28:21Speaker 4: of safety first, efficacy second in products. So the point
- 28:26Speaker 4: is is that you know that can be very variable
- 28:30Speaker 4: and we need to make sure that we can minimize
- 28:32Speaker 4: that so again the patients will actually take it. So
- 28:34Speaker 4: obviously we have data that supports that in terms of
- 28:37Speaker 4: our ability to be absorbed correctly and consistently. Given the
- 28:42Speaker 4: formulation that we have and you know that's again for
- 28:46Speaker 4: those patients. Again, we're trying to really focus on those
- 28:49Speaker 4: patients that are not where we want them to be.
- 28:52Speaker 4: And that's a tough chore because, as you just said,
- 28:55Speaker 4: you when I look at a patient, I'm going to
- 28:57Speaker 4: get multiple things. I might start with sleep because that's
- 28:59Speaker 4: the was critical in your eye from a reset, which
- 29:02Speaker 4: I couldn't argue makes a lot of sense to me
- 29:05Speaker 4: because I would like to sleep a little bit better myself.
- 29:08Speaker 4: But that's where all the factors come in. But you know,
- 29:11Speaker 4: down on level two or three or four, something might
- 29:14Speaker 4: be having impact on primary you know, priority number one,
- 29:18Speaker 4: a product that you can't tolerate very well, or something
- 29:21Speaker 4: else would be an example of that. I love it.
- 29:25Speaker 3: I love the collaboration between business development, getting optacles out
- 29:31Speaker 3: of the way for payment in in where pharmacists are struggling.
- 29:36Speaker 3: That's the side of I've been in pharmacy now twenty
- 29:39Speaker 3: two years and that is the side of art of
- 29:42Speaker 3: this business. That's the most frustrating for me is where
- 29:45Speaker 3: pharmacists desperately want to help their patient and they can't
- 29:48Speaker 3: get something paid for because of some you know, PBM
- 29:51Speaker 3: issue or something, and Sonya, I'm sure you get frustrated
- 29:54Speaker 3: about that and managing a specific disease state for patient.
- 30:00Speaker 5: Very frustrating.
- 30:02Speaker 4: All right, well we should fix that one. Then we
- 30:04Speaker 4: fixed the world.
- 30:06Speaker 3: It's all happening right now. Actually, the churn and the
- 30:08Speaker 3: play tectonics of our industry are moving finally and we're
- 30:12Speaker 3: seeing some better outcomes. But Sonya, this has been a
- 30:17Speaker 3: thrill for us to be able to dial into somebody
- 30:19Speaker 3: who really understands what some of our patients, what some
- 30:23Speaker 3: of our people are going through. And I think sensitivity
- 30:26Speaker 3: comes in when we get older and you're seeing so
- 30:30Speaker 3: many changes. Patients are reaching out to you for other
- 30:33Speaker 3: things that aren't necessarily pharmacological, about their metabolism and about
- 30:38Speaker 3: their diet and about just living better. So thank you
- 30:41Speaker 3: for being such a great resource today.
- 30:43Speaker 5: Oh my pleasure. Happy to help.
- 30:46Speaker 3: And Steve, and it's always good seeing you here in
- 30:48Speaker 3: the Pharmacy Podcast Network studios and our hometown Brownsville, Pennsylvania.
- 30:53Speaker 3: I'm proud of this, Sonya. We were just sharing before
- 30:57Speaker 3: we were recording that we had a bunch of HECE
- 31:00Speaker 3: goalers come into the studio to do a podcast about
- 31:04Speaker 3: a play that they're working on within our community.
- 31:06Speaker 5: So fun Well, I live in Branson, so you know,
- 31:10Speaker 5: it's it's live entertainment everywhere in our city. I love
- 31:14Speaker 5: those sorts of things, love those live shows.
- 31:16Speaker 4: Aymen, and our youth being involved in theater and things
- 31:19Speaker 4: like that can have to be continued to be supported.
- 31:23Speaker 4: So it's good to say. And ironically it's great that
- 31:27Speaker 4: Todd and I live in the same area of a
- 31:29Speaker 4: very small town in western Pennsylvania. And who would know,
- 31:33Speaker 4: who would ever thought that two would cross that Pugle
- 31:36Speaker 4: CEO and ahead of a very exciting, dynamic podcast platform
- 31:40Speaker 4: for pharmacy, and we met in San Diego, and we
- 31:43Speaker 4: met San Diego. But you know, Toddy, I mean we
- 31:45Speaker 4: shouldn't understate the fact that what you're doing for pharmacists
- 31:49Speaker 4: and your platform and what you've built, you know, I submit,
- 31:53Speaker 4: I've been doing this for over thirty years on the
- 31:56Speaker 4: manufacturing side, and I have great respect and value for
- 32:01Speaker 4: physicians and nurses and pharmacists. But I do have a
- 32:05Speaker 4: saft spot for pharmacists because you know, it's a tough
- 32:09Speaker 4: world for them and uh, just to demands on the
- 32:13Speaker 4: amount of medications they're filling. The responsibility that the huge
- 32:17Speaker 4: responsibility have of of treating patients and and most pharmacists
- 32:23Speaker 4: never get the credit that they do. They're they're either
- 32:25Speaker 4: primary or a supplement to the physician, and there are
- 32:29Speaker 4: a lot more than filling a prescription, and we do
- 32:32Speaker 4: need to continue to find ways to support them. And
- 32:35Speaker 4: we hope that's one of the things that makes you
- 32:38Speaker 4: a ral a little different. A lot of generic companies
- 32:40Speaker 4: they don't take the time or invest in supporting because
- 32:44Speaker 4: you know, traditionally generic companies, you know, we supply PROCs
- 32:48Speaker 4: to the wholesalers and PROCs sell as they sell. But
- 32:51Speaker 4: you know, we have a responsibility uh to be out
- 32:54Speaker 4: there and supporting the people. Uh and the pharmacists are
- 32:57Speaker 4: our top on our list. So we're we're to continue
- 33:00Speaker 4: to work on these type of podcasts and continue to
- 33:02Speaker 4: raise issues and challenges, and we have to be respectful
- 33:05Speaker 4: to all the pieces. It's about helping the patient. It's
- 33:08Speaker 4: about making sure a pharmacist has time to spend with
- 33:11Speaker 4: the patients, similar to that as a doctor doctor wants
- 33:13Speaker 4: more time to We want to be able to allow
- 33:16Speaker 4: them to do that and still be able to be
- 33:18Speaker 4: And I know this sounds an ugly word sometimes, but
- 33:22Speaker 4: they have to be profitable. They can't well, they can't
- 33:25Speaker 4: continue to serve their patients as a farmer, as a manufacturer,
- 33:29Speaker 4: as a physician. So we've got to find that that
- 33:32Speaker 4: good place where the patient is served first and foremost.
- 33:36Speaker 4: And all we can do is so we will always listen,
- 33:39Speaker 4: and through relationships with you, TOADD and others through Sonia,
- 33:43Speaker 4: we hope that well we will listen first and foremost,
- 33:46Speaker 4: and we will listen and we will learn, and as
- 33:49Speaker 4: a supplier of medication, we will take that insight to
- 33:52Speaker 4: make and match up. If we're talking about we have
- 33:55Speaker 4: to do individual medicine to patients, then it's our job
- 33:58Speaker 4: to make sure that we're looking very close at our
- 34:00Speaker 4: drug portfolio, at what we're doing as a company, how
- 34:03Speaker 4: that matches up to the different needs within the health
- 34:07Speaker 4: care system and supply, so ultimately we get that good outcome.
- 34:11Speaker 4: I just want to say outcome one more.
- 34:12Speaker 3: Time time, Sonya. We're headed to Columbus, Ohio for the
- 34:19Speaker 3: National Community Pharmacist Association's annual meeting in October. Do you
- 34:23Speaker 3: ever make any of the national conferences at all?
- 34:27Speaker 5: I typically just do the niche that I'm in, you know,
- 34:31Speaker 5: the customized medicine, the endocrinology stuff.
- 34:37Speaker 3: We are preparing for the NCPA. You're all pharma. We'll
- 34:40Speaker 3: have a presence there. A shout out to our listeners.
- 34:43Speaker 3: If you'd like to meet up with your raw we
- 34:46Speaker 3: can arrange those meetings for you, and really digging down
- 34:48Speaker 3: into supporting you. If it's a pain management focus that
- 34:52Speaker 3: you're on, if it's the thyroid that you're focused on,
- 34:55Speaker 3: let us help support you. This is not only from
- 34:58Speaker 3: a product perspective, but even marketing perspective to really open
- 35:01Speaker 3: up those additional channels for you. So a shout out
- 35:05Speaker 3: to everyone attending the NCPA.
- 35:07Speaker 4: Yeah, I guess we can conclude Todd by saying, first
- 35:11Speaker 4: of all, we do want to listen, and I said
- 35:14Speaker 4: that a moment ago, but we're only going to get
- 35:16Speaker 4: better as an organization servicing our patients and customers if
- 35:20Speaker 4: we listen. So that's why we do things like attending
- 35:23Speaker 4: the NCPA. Also, we have our website, which is you're
- 35:26Speaker 4: allfarmer dot com. We're always where a lot of information
- 35:31Speaker 4: is the most importantly all our full prescribing information, including
- 35:34Speaker 4: our box warning on leave out our ox and capsules
- 35:38Speaker 4: or sodium capsules. So most importantly is that we want
- 35:43Speaker 4: to exchange the level of information and knowledge and then
- 35:46Speaker 4: hopefully the right patient will get the right product with
- 35:49Speaker 4: the right support.
- 35:50Speaker 3: Absolutely, Doctor sonyo Obrian, thank you for being our special
- 35:54Speaker 3: guest today and a shout out to our pharmacists and
- 35:57Speaker 3: technicians for listening to the Pharmacy Podcast. Please subscribe on
- 36:01Speaker 3: any of your favorite podcast players and once again take
- 36:04Speaker 3: a look at your raw that's y R Alpharma dot
- 36:09Speaker 3: com and we'll see with them.
- 36:11Speaker 6: Sidinlevothyroxin sodium capsules are l thyroxine t for indicated for
- 36:29Speaker 6: use in adults and pediatric patients six years and older
- 36:32Speaker 6: with hypothyroidism. Levothyroxin sodium capsules can also be used for
- 36:36Speaker 6: pituitary thyrotrophin suppression. Thyroid hormones including levothyroxin sodium capsules should
- 36:42Speaker 6: not be used for the treatment of obesity or for
- 36:45Speaker 6: weight loss. Doses beyond the range of daily hormonal requirements
- 36:48Speaker 6: may produce serious or even life threatening manifestations of toxicity.
- 36:52Speaker 6: Levothyroxin sodium capsules are not indicated for suppression of benign
- 36:56Speaker 6: thyroid nodules and non toxic diffuse goiter in iodiine sophic
- 37:00Speaker 6: patients or for the treatment of transient hypothyroidism during the
- 37:03Speaker 6: recovery phase of subacute thyroiditis. Levothyroxin sodium capsules are contraindicated
- 37:09Speaker 6: in patients with uncorrected adrenal insufficiency. For elderly patients and
- 37:13Speaker 6: those with underlying cardiovascular conditions, starting with a lower dose
- 37:17Speaker 6: is recommended due to the heightened risk of cardiac adverse reactions,
- 37:21Speaker 6: including atrial fibrillation. Oral thyroid hormone drugs should not be
- 37:24Speaker 6: used to treat mixedema coma, and replacement glucocorticoids are necessary
- 37:28Speaker 6: for patients with concomitant adrenal insufficiency. Before initiating levothyroxin sodium
- 37:33Speaker 6: capsules to prevent hyperthyroidism, or for the incomplete treatment of hypothyroidism,
- 37:38Speaker 6: Proper dose titration and careful monitoring are essential. Diabetic patients
- 37:42Speaker 6: should carefully monitor glycemic control after starting, changing, or discontinuing
- 37:47Speaker 6: thyroid hormone therapy, since glycemic control may worsen. In diabetic patients,
- 37:51Speaker 6: Decreased bone mineral density associated with thyroid hormone over replacement
- 37:55Speaker 6: may occur. Adverse reactions associated with levothyroxin sodium capassus primarily
- 38:00Speaker 6: reflect symptoms of hyperthyroidism due to overdosage, including arrhythmias, heart attack, dyspmia,
- 38:06Speaker 6: muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite,
- 38:13Speaker 6: weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash.
- 38:19Speaker 6: Patients should ask their doctor if levothyroxin sodium capsules are
- 38:22Speaker 6: right for them. For more information and full prescribing information,
- 38:26Speaker 6: including boxed warning and important safety information, visit www dot
- 38:30Speaker 6: urlpharma dot com